The Laboratory in the Multidisciplinary Diagnosis of Differences or Disorders of Sex Development (DSD): III) Biochemical and Genetic Markers in the 46,XYIV) Proposals for the Differential Diagnosis of DSD

Overview

Journal Adv Lab Med

Publisher De Gruyter

Specialty Biochemistry

Date 2023 Jun 26

PMID 37360892

Authors

Maria Luisa Granada

Laura Audi

Affiliations

Soon will be listed here.

Abstract

Objectives: 46,XY differences/disorders of sex development (DSD) involve an abnormal gonadal and/or genital (external and/or internal) development caused by lack or incomplete intrauterine virilization, with or without the presence of Müllerian ducts remnants.

Content: Useful biochemical markers for differential diagnosis of 46,XY DSD include hypothalamic-pituitary-gonadal hormones such as luteinizing and follicle-stimulating hormones (LH and FSH; in baseline or after LHRH stimulation conditions), the anti-Müllerian hormone (AMH), inhibin B, insulin-like 3 (INSL3), adrenal and gonadal steroid hormones (including cortisol, aldosterone, testosterone and their precursors, dihydrotestosterone and estradiol) and the pituitary ACTH hormone. Steroid hormones are measured at baseline or after stimulation with ACTH (adrenal hormones) and/or with HCG (gonadal hormones).

Summary: Different patterns of hormone profiles depend on the etiology and the severity of the underlying disorder and the age of the patient at diagnosis. Molecular diagnosis includes detection of gene dosage or copy number variations, analysis of candidate genes or high-throughput DNA sequencing of panels of candidate genes or the whole exome or genome.

Outlook: Differential diagnosis of 46,XX or 46,XY DSD requires a multidisciplinary approach, including patient history and clinical, morphological, imaging, biochemical and genetic data. We propose a diagnostic algorithm suitable for a newborn with DSD that focuses mainly on biochemical and genetic data.

References

Bouty A, Ayers K, Pask A, Heloury Y, Sinclair A . The Genetic and Environmental Factors Underlying Hypospadias. Sex Dev. 2015; 9(5):239-259. PMC: 5012964. DOI: 10.1159/000441988. View

Freire A, Grinspon R, Rey R . Importance of Serum Testicular Protein Hormone Measurement in the Assessment of Disorders of Sex Development. Sex Dev. 2017; 12(1-3):30-40. DOI: 10.1159/000479572. View

Aksglaede L, Sorensen K, Boas M, Mouritsen A, Hagen C, Jensen R . Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab. 2010; 95(12):5357-64. DOI: 10.1210/jc.2010-1207. View

Josso N, Belville C, Clemente N, Picard J . AMH and AMH receptor defects in persistent Müllerian duct syndrome. Hum Reprod Update. 2005; 11(4):351-6. DOI: 10.1093/humupd/dmi014. View

Bouvattier C, Carel J, Lecointre C, David A, Sultan C, Bertrand A . Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J Clin Endocrinol Metab. 2002; 87(1):29-32. DOI: 10.1210/jcem.87.1.7923. View

Mongan N, Tadokoro-Cuccaro R, Bunch T, Hughes I . Androgen insensitivity syndrome. Best Pract Res Clin Endocrinol Metab. 2015; 29(4):569-80. DOI: 10.1016/j.beem.2015.04.005. View

Akcay T, Fernandez-Cancio M, Turan S, Guran T, Audi L, Bereket A . AR and SRD5A2 gene mutations in a series of 51 Turkish 46,XY DSD children with a clinical diagnosis of androgen insensitivity. Andrology. 2014; 2(4):572-8. DOI: 10.1111/j.2047-2927.2014.00215.x. View

Mares L, Vilchis F, Chavez B, Ramos L . Molecular genetic analysis of AKR1C2-4 and HSD17B6 genes in subjects 46,XY with hypospadias. J Pediatr Urol. 2020; 16(5):689.e1-689.e12. DOI: 10.1016/j.jpurol.2020.07.001. View

Forest M, Cathiard A, Bertrand J . Evidence of testicular activity in early infancy. J Clin Endocrinol Metab. 1973; 37(1):148-51. DOI: 10.1210/jcem-37-1-148. View

10.

Ferlin A, Zuccarello D, Garolla A, Selice R, Vinanzi C, Ganz F . Mutations in INSL3 and RXFP2 genes in cryptorchid boys. Ann N Y Acad Sci. 2009; 1160:213-4. DOI: 10.1111/j.1749-6632.2008.03784.x. View

11.

Maimoun L, Philibert P, Cammas B, Audran F, Bouchard P, Fenichel P . Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab. 2010; 96(2):296-307. DOI: 10.1210/jc.2010-1024. View

12.

Imperato-McGinley J, Zhu Y . Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Mol Cell Endocrinol. 2003; 198(1-2):51-9. DOI: 10.1016/s0303-7207(02)00368-4. View

13.

Ogata T, Laporte J, Fukami M . MAMLD1 (CXorf6): a new gene involved in hypospadias. Horm Res. 2009; 71(5):245-52. DOI: 10.1159/000208797. View

14.

Gaspari L, Sampaio D, Paris F, Audran F, Orsini M, Neto J . High prevalence of micropenis in 2710 male newborns from an intensive-use pesticide area of Northeastern Brazil. Int J Androl. 2012; 35(3):253-64. DOI: 10.1111/j.1365-2605.2011.01241.x. View

15.

Baetens D, Mladenov W, Delle Chiaie B, Menten B, Desloovere A, Iotova V . Extensive clinical, hormonal and genetic screening in a large consecutive series of 46,XY neonates and infants with atypical sexual development. Orphanet J Rare Dis. 2014; 9:209. PMC: 4271496. DOI: 10.1186/s13023-014-0209-2. View

16.

Fernandez M, Olmos B, Granada A, Lopez-Espinosa M, Molina-Molina J, Fernandez J . Human exposure to endocrine-disrupting chemicals and prenatal risk factors for cryptorchidism and hypospadias: a nested case-control study. Environ Health Perspect. 2008; 115 Suppl 1:8-14. PMC: 2174399. DOI: 10.1289/ehp.9351. View

17.

Wang H, Zhu H, Wang N, Cheng T, Han B, Zhao S . Somatic mosaicism of androgen receptor gene in an androgen insensitivity syndrome patient conceived through assisted reproduction technique. Mol Genet Genomic Med. 2019; 7(10):e00906. PMC: 6785456. DOI: 10.1002/mgg3.906. View

18.

Baranowski E, Arlt W, Idkowiak J . Monogenic Disorders of Adrenal Steroidogenesis. Horm Res Paediatr. 2018; 89(5):292-310. PMC: 6067656. DOI: 10.1159/000488034. View

19.

Ahmed S, Achermann J, Arlt W, Balen A, Conway G, Edwards Z . Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015). Clin Endocrinol (Oxf). 2015; 84(5):771-88. PMC: 4855619. DOI: 10.1111/cen.12857. View

20.

Batista R, Mendonca B . Integrative and Analytical Review of the 5-Alpha-Reductase Type 2 Deficiency Worldwide. Appl Clin Genet. 2020; 13:83-96. PMC: 7167369. DOI: 10.2147/TACG.S198178. View